MLLT3 and leukemia: We then performed the high-density CRISPR gene tiling scans in MLL-AF9-Cas9+ leukemia (data S10; target density ranged from 2.5 to 3.2 amino acids per sgRNA) and aligned the smoothened NCS to the 2D peptide positions of each targeted protein (Fig. 7, middle panels).